Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARD | Q03181 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | FABP4 | P15090 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4633389 | 1.00 | AKR1B1 (0.44) | AKR1B1FNTAFNTBGPR84PPARG | |
| SCHEMBL4632410 | 1.00 | AKR1B1 (0.44) | AKR1B1FNTAFNTBGPR84PPARG | |
| SCHEMBL4922927 | 0.94 | AKR1B1 (0.54) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL4633104 | 0.94 | AKR1B1 (0.54) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL4633100 | 0.94 | AKR1B1 (0.54) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL7057634 | 0.92 | GPR84 (0.56) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL7057637 | 0.92 | GPR84 (0.56) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL21176641 | 0.86 | FFAR3 (0.48) | AKR1B1FNTAFNTBGPR84PPARG | |
| SCHEMBL11055349 | 0.86 | FFAR3 (0.48) | AKR1B1FNTAFNTBGPR84PPARG | |
| SCHEMBL5155698 | 0.81 | FNTA (0.53) | AKR1B1FNTAFNTBGPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015144485-A1 | OLFACTORY BOOSTERS | HENKEL AG & CO. KGAA (DE) | 2015-10-01 | — | — | WO | claimed |
| EP-2620769-B1 | METHOD OF SCREENING DAMP-DRY MALODOR INHIBITOR AND METHOD OF EVALUATING DAMP-DRY MALODOR INHIBITOR | KAO CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| WO-2015144485-A1 | OLFACTORY BOOSTERS | HENKEL AG & CO. KGAA (DE) | 2015-10-01 | — | — | WO | disclosed |
| CN-103270415-B | The screening technique of half-dried odor control additive and the evaluation method of half-dried odor control additive | KAO CORP. (JP) | 2015-09-09 | — | — | CN | disclosed |
| US-8771660-B2 | Method of screening for a damp-dry malodor inhibitor and method of evaluating damp-dry malodor inhibitor by microbial production of 4-methyl-3-hexenoic acid | KAO CORPORATION (JP) | 2014-07-08 | — | — | US | disclosed |
| EP-2620769-A9 | METHOD FOR SCREENING HALF-DRY SMELL DEODORIZER AND METHOD FOR EVALUATING HALF-DRY SMELL DEODORIZER | Kao Corporation (JP) | 2014-02-19 | — | — | EP | disclosed |
| CN-103270415-A | Method for screening half-ry smell deodorizer and method for evaluating half-<wbr/>dry smell deodorizer | KAO CORP | 2013-08-28 | — | — | CN | disclosed |
| US-20130210061-A1 | Method of Screening Damp-Dry Malodor Inhibitor and Method of Evaluating Damp-Dry Malodor Inhibitor | KAO CORPORATION (JP) | 2013-08-15 | — | — | US | disclosed |
| EP-2620769-A1 | METHOD FOR SCREENING HALF-DRY SMELL DEODORIZER AND METHOD FOR EVALUATING HALF-DRY SMELL DEODORIZER | Kao Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-20080260670-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2008-10-23 | — | — | US | disclosed |
| CN-101267860-A | Organic compounds | GIVAUDAN SA (CH) | 2008-09-17 | — | — | CN | disclosed |
| EP-1926531-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007033508-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080260670-A1 | Organic Compounds | OR10J3, OR51E2, ELOVL1 | AKR1B1 945/4885FNTA 1445/4885FNTB 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.